Male Urinary Incontinence Products Market Size, Share, and Growth Forecast 2026 - 2033

The global male urinary incontinence products market size is expected to be valued at US$ 7.5 billion in 2026 and is projected to reach US$ 11.2 billion, growing at a CAGR of 5.9% between 2026 and 2033.

Market growth is primarily driven by the rising global prevalence of prostate disorders and an aging male population. According to the World Health Organization (WHO), benign prostatic hyperplasia and prostate cancer remain among the most common urological conditions affecting aging men worldwide. This growing disease burden is increasing post-surgical and age-related incontinence cases requiring management products. Additionally, rising awareness and reduced social stigma around incontinence care are encouraging more men to seek diagnosis and treatment, supporting steady market expansion through the forecast period.

Drivers - Rising Global Prevalence of Prostate Disorders and Aging Population

The increasing prevalence of prostate disorders and the rapidly expanding aging male population are major factors driving demand for male urinary incontinence management solutions. According to the World Health Organization (WHO), prostate cancer is one of the most frequently diagnosed cancers among men globally, with the burden expected to rise as populations age. The International Agency for Research on Cancer (IARC) estimated that prostate cancer accounted for more than 1.4 million new cases worldwide in 2022, making it the second most commonly diagnosed cancer among men.

Growing numbers of prostate cancer treatments, particularly radical prostatectomy procedures, are contributing to higher cases of post-surgical urinary incontinence.

Additionally, age-related conditions such as benign prostatic hyperplasia (BPH) are increasing among elderly men, creating sustained demand for continence management products. According to the National Institute on Aging (NIA), older adults represent one of the fastest-growing demographic groups globally, with the population aged 65 years and above projected to increase significantly in the coming decades.

Rising life expectancy, expanding urology care access, and increasing diagnosis rates are encouraging greater adoption of absorbent pads, external collection devices, and protective underwear across hospitals, home care settings, and long-term care facilities. These demographic and clinical trends are expected to maintain the steady growth momentum of the market through 2033.

Restraints - High Cost of Advanced Incontinence Management Products

Advanced male urinary incontinence management products, including premium absorbent solutions, external collection devices, and specialized continence systems, often involve higher costs compared with conventional alternatives. Long-term usage requirements create financial challenges, particularly for elderly patients who require continuous product support and may have limited income sources. Variations in insurance reimbursement policies across different healthcare systems further influence affordability and access to advanced solutions.

Cost sensitivity remains a major consideration for both patients and healthcare providers when selecting continence management products. In developing markets, limited reimbursement coverage and lower awareness regarding premium solutions may restrict adoption of advanced products. Manufacturers are therefore focusing on developing cost-effective product ranges, improving manufacturing efficiencies, and expanding affordable options to address diverse patient needs while maintaining product quality and comfort across different healthcare settings.

Opportunities - Expansion of External Collection Devices for Active Lifestyle Management

Growing demand for discreet, comfortable, and lifestyle-compatible urinary management solutions is creating significant opportunities for external collection device manufacturers. These products provide improved confidence, mobility, and convenience for men managing chronic incontinence while maintaining active personal and professional routines. Increasing preference for minimally invasive alternatives compared with traditional absorbent products is accelerating adoption across home care and outpatient settings.

Companies such as Coloplast A/S and Hollister Incorporated continue expanding their external catheter portfolios with improved materials, enhanced adhesive technologies, and extended-wear designs focused on patient comfort. Rising recommendations from healthcare professionals, increasing awareness of non-invasive management options, and expanding elderly populations are expected to support market penetration. As healthcare systems increasingly emphasize personalized and home-based care solutions, external collection devices are positioned to capture rising demand through 2033.

Product Insights

Absorbent pads represent the leading product segment, holding around 31% share of the male urinary incontinence products market in 2026. Their dominance is supported by affordability, easy availability, discreet designs, and suitability across mild to severe incontinence conditions. These products serve as the primary management option for many patients due to their convenience, disposable format, and compatibility with daily activities. Strong distribution through pharmacies, supermarkets, online platforms, and healthcare facilities further supports recurring purchases among long-term users.

External collection devices are expected to be the fastest-growing product segment during the forecast period. The segmental growth is driven by increasing preference for non-invasive, comfortable, and lifestyle-friendly urinary management solutions. Improvements in silicone-based materials, adhesive technologies, and product designs are enhancing comfort, reliability, and user acceptance, particularly among elderly and post-surgical patients seeking alternatives to traditional absorbent products.

Incontinence Type Insights

Stress urinary incontinence represents the leading segment, driven by its high occurrence among men undergoing prostate surgery, particularly post-prostatectomy patients. Weakening of pelvic floor muscles and age-related changes continue contributing to higher diagnosis rates. Consistent demand for absorbent products, external collection devices, and surgical interventions supports segment growth. Urology clinics and specialist care centers continue identifying stress incontinence as a major condition requiring structured management approaches.

Urge urinary incontinence is projected to be the fastest-growing segment through the forecast period, supported by increasing prevalence of benign prostatic hyperplasia and age-associated bladder dysfunction among men. Rising diagnosis rates, improved awareness of urinary disorders, and expanding access to urological evaluations are encouraging earlier treatment adoption. Growing utilization of medications, behavioral therapies, and supportive continence products further strengthens demand for urge incontinence management solutions.

End-Users Insights

Hospitals are expected to maintain their leading position in the market, supported by advanced urology departments, surgical capabilities, and comprehensive diagnostic infrastructure. Hospitals manage a significant proportion of complex urinary incontinence cases, including post-prostatectomy patients and individuals requiring surgical interventions. Concentration of specialist physicians, reimbursement support, and availability of advanced treatment facilities continue reinforcing hospital-based product adoption across developed and emerging healthcare systems.

Home care settings are the fastest-growing end-user segment, driven by increasing preference for personalized and convenient chronic care management outside traditional healthcare facilities. Growth in elderly populations, expansion of telehealth services, and rising availability of direct-to-consumer continence products are supporting this transition. Improved home monitoring solutions and caregiver support services are further encouraging adoption of urinary incontinence management products within residential care environments.

North America Male Urinary Incontinence Products Market Trends and Insights

North America is projected to dominate the global market while holding around 41% in 2026, supported by advanced urology care infrastructure, strong reimbursement frameworks, and widespread adoption of continence management products. Rising prevalence of prostate disorders, increasing geriatric population, and established healthcare systems continue to drive the demand for urinary incontinence products across hospitals, specialty clinics, and home care settings.

The region also benefits from high awareness regarding urinary health management, extensive availability of advanced medical devices, and a strong presence of leading medical device manufacturers. Continuous innovation in external collection devices, catheters, and absorbent solutions, along with favorable insurance coverage and expanding home healthcare adoption, further reinforces North America's leadership position in the global market.

U.S. Male Urinary Incontinence Products Market Size

The U.S. is projected to hold around 83% share of the North American market in 2026, supported by advanced healthcare infrastructure, extensive insurance coverage, and strong adoption of continence management solutions. High prostate cancer screening rates and increasing diagnoses of urological disorders continue to support product demand nationwide.

The presence of leading medical product manufacturers, including Hollister Incorporated and Coloplast A/S, strengthens product availability and innovation. Expanding Medicare coverage for incontinence supplies, a rising elderly population, and a growing preference for home-based care solutions further reinforce the country's dominant position within the North American market.

Europe Male Urinary Incontinence Products Market Trends and Insights

Europe remains a significant market for male urinary incontinence products, supported by comprehensive public healthcare systems, strong urology care networks, and increasing demand for continence management solutions among aging populations. Government-supported healthcare programs, improved diagnostic capabilities, and widespread reimbursement coverage encourage greater adoption of advanced urinary care products.

Rising prevalence of prostate disorders, increasing elderly demographics, and continuous investments in healthcare modernization continue influencing regional market growth. Strong regulatory standards, established medical device manufacturers, and growing awareness regarding male urinary health further strengthen Europe's position as a mature yet steadily developing market.

Germany Male Urinary Incontinence Products Market Size

Germany is expected to hold a 26% share of the European market in 2026, supported by its advanced hospital infrastructure, comprehensive statutory health insurance system, and strong adoption of medical devices. Rising prostate disorder diagnosis and increasing elderly healthcare requirements continue driving demand for urinary management products.

The country's well-established urology care ecosystem, advanced medical technology adoption, and presence of specialized healthcare providers encourage continuous product utilization. Supportive reimbursement policies and increasing awareness among patients and caregivers further reinforce Germany's leadership within the European market.

U.K. Male Urinary Incontinence Products Market Size

The U.K. is anticipated to hold a significant share of the European male urinary incontinence products market in 2026, supported by National Health Service accessibility, expanding private healthcare investment, and increasing awareness of male continence management options. Strong diagnostic capabilities and structured healthcare pathways continue to support consistent product adoption.

Growing demand for home healthcare solutions, an increasing elderly population, and improved patient education programs are accelerating market development. Regulatory support, healthcare modernization initiatives, and wider availability of advanced urinary management products strengthen the United Kingdom's contribution to the European regional market.

Asia Pacific Male Urinary Incontinence Products Market Trends and Insights

Asia Pacific is emerging as the fastest-growing market for male urinary incontinence products, supported by expanding healthcare infrastructure, rising awareness of urological disorders, and increasing investments in elderly care services. Rapid urbanization, improving diagnostic facilities, and growing adoption of advanced medical devices are accelerating regional demand.

Increasing healthcare expenditure, government initiatives supporting aging populations, and expansion of private hospitals are creating new opportunities across developing economies. Growing awareness regarding prostate health, improved access to continence products, and rising acceptance of professional care solutions continue to strengthen market growth throughout the region.

India Male Urinary Incontinence Products Market Size

India is expected to hold about 17% share of the Asia Pacific male urinary incontinence products market in 2026, supported by expanding urology care infrastructure, increasing healthcare investments, and rising awareness of prostate-related disorders. Growing hospital networks across metropolitan and Tier II cities are improving access to diagnosis and treatment options.

Government healthcare programs, an increasing elderly population, and improving affordability of medical devices continue to support product adoption. Rising healthcare awareness and expansion of organized home healthcare services are further strengthening India's contribution to the Asia Pacific market.

Japan Male Urinary Incontinence Products Market Size

Japan is projected to hold a substantial share of the Asia Pacific male urinary incontinence products market in 2026, supported by its advanced healthcare ecosystem, rapidly aging population, and strong medical device manufacturing capabilities. High demand for urological care among elderly individuals continues to sustain adoption of continence management products.

Domestic manufacturers, advanced healthcare technologies, and well-developed reimbursement systems support continuous innovation and accessibility. Increasing focus on quality aging, preventive healthcare, and patient comfort further reinforces Japan's significant position within the Asia Pacific market.

The global male urinary incontinence products market is moderately consolidated, with several established medical device and hygiene product manufacturers holding a significant share alongside specialized regional players. Leading companies are prioritizing research and development investment toward discreet, comfortable product design and extended-wear technology to differentiate their offerings. Strategic partnerships with urology clinics and expansion into home delivery channels are common growth strategies.

Key differentiators among market leaders include product comfort, absorbency performance, and brand discretion. Additionally, subscription-based direct-to-home delivery models are emerging as a notable business trend, allowing patients to access products privately and consistently.

Key Industry Developments

• In April 2026, Wellspect HealthCare launched Surity Male External Catheter in the U.S., expanding its continence care portfolio. The non-invasive device is designed for men managing urinary incontinence, focusing on improved comfort, dryness, dignity, and ease of use. The launch addresses growing demand for external urinary management solutions among patients requiring long-term continence support.
• In April 2025, Ontex finalized the divestment of its Brazilian operations to Softys, representing a strategic move under its portfolio optimization strategy. The transaction enables Ontex to concentrate on its core markets, streamline operations, and enhance overall business efficiency.
• In February 2025, First Quality Enterprises, LLC entered into a definitive agreement to acquire Henkel’s Retailer Brands business in North America. Following the acquisition, First Quality established First Quality Home Care Products as a dedicated business division within the First Quality Group to strengthen its presence in the home care products segment.